Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Nov;69 Suppl 2(Suppl 2):S205-14.
doi: 10.1093/geronb/gbu105.

Prevalence of bacterial vaginosis and Candida among postmenopausal women in the United States

Affiliations

Prevalence of bacterial vaginosis and Candida among postmenopausal women in the United States

Joscelyn N Hoffmann et al. J Gerontol B Psychol Sci Soc Sci. 2014 Nov.

Abstract

Objectives: To describe the prevalence of bacterial vaginosis (BV) and Candida among community-dwelling postmenopausal women in the United States and determine their change with age, using estimates based on Waves 1 and 2 of the National Social Life, Health and Aging Project (NSHAP).

Method: Self-administered vaginal swabs were collected in-home from women aged 57-85 (n = 1,016) in Wave 1 and again 5 years later in Wave 2 (n = 883). Gram-stained specimens were evaluated for BV using the Nugent score as well as presence of Candida.

Results: BV was prevalent in 23% and 38% of postmenopausal women in Waves 1 and 2 and increased with age. Women initially categorized with BV in Wave 1 were more than 10 times as likely to be categorized with BV in Wave 2, relative risk ratio (RRR) = 10.5; 95% confidence interval (CI) (4.45-24.7); p < .001, whereas women initially categorized as intermediate in Wave 1 were five times more likely to have a BV categorization, RRR = 5.0; 95% CI (2.56-9.75); p < .001. Although the presence of Candida was similar in both waves (6% and 5%), its relationship with age only became evident in Wave 2, with odds of detecting Candida decreasing by 7% with each year of age, OR = 0.93, 95% CI (0.88, 0.98); p = .010.

Discussion: In Wave 2, the prevalence of BV was higher and increased with age while the prevalence of Candida was low and declined with age. A 5-year age increase contributed to the prevalence change across waves. Methods refinements in Wave 2 improved the detection of BV and Candida and clarified their relationship with age.

Keywords: Bacterial vaginosis; Candida; Population; Postmenopause; Self-collection; Vaginal swab..

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Effect of chronological age on the predicted Nugent score (95% CIs) in Waves 1 (ages 57–85) and 2 (ages 62–90).
Figure 2.
Figure 2.
Wave 2 differences between age groups in proportions of three diagnostic categories based on Nugent score: normal (0–3), intermediate (4–6), bacterial vaginosis (7–10).
Figure 3.
Figure 3.
Wave differences in the effect of age on predicted probability (95% CIs) of diagnostic categories based on Nugent score (normal, intermediate, and bacterial vaginosis) in Waves 1 (ages 57–85) and 2 (ages 62–90).
Figure 4.
Figure 4.
Effect of age on predicted prevalence (95% CIs) of Candida in Waves 1 and 2.

Similar articles

Cited by

References

    1. Achkar J. M., Fries B. C. (2010). Candida infections of the genitourinary tract. Clinical Microbiology Reviews, 23, 253–273. 10.1128/CMR.00076-09 - PMC - PubMed
    1. Allsworth J. E., Peipert J. F. (2007). Prevalence of bacterial vaginosis: 2001-2004 National Health and Nutrition Examination Survey data. Obstetrics and Gynecology, 109, 114–120. 10.1097/01.AOG.0000247627.84791.91 - PubMed
    1. Alnaif B., Drutz H. P. (2000). Bacterial vaginosis increases in pessary users. International Urogynecology Journal and Pelvic Floor Dysfunction, 11, 219–222 Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/11005473 - PubMed
    1. Amsel R., Totten P. A., Spiegel C. A., Chen K. C., Eschenbach D., Holmes K. K. (1983). Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. The American Journal of Medicine, 74, 14–22 Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/6600371 - PubMed
    1. Anderson M. R., Klink K., Cohrssen A. (2004). Evaluation of vaginal complaints. JAMA: the journal of the American Medical Association, 291, 1368–1379. 10.1001/jama.291.11.1368 - PubMed

Publication types